Form D · Pharmaceuticals

Dignify Therapeutics, LLC

Research Triangle Park, NC · CIK 0001622906

Offering snapshot reported Sep 25, 2026 · SEC filing

Reported sold
$800K
Offering amount: $3M
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 15, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 25, 2026Initial$800,000No comparison2SEC filing
Feb 25, 2015Amendment$3,445,868$3,345,871vs Oct 24, 20147SEC filing
Oct 24, 2014Initial$99,997No comparison1SEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-598830

Source: Form D, filed Sep 25, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Edward C. Burgard Director
Anthony Di Tonno Director, Executive
Fred Eshelman Director
Eric Green Director
Venkateswarlu Karicheti Promoter
Mary Katofiasc Promoter
Florenta Aura Kullmann Promoter
Neil Kurtz Director
Lesley Marson Promoter
Howard Palefsky Director
Daniel J Ricca Director, Promoter
Karl B. Thor Director
Tatyana Touzova Promoter
Ebrahim Versi Director, Promoter
Benny Ward Director, Executive, Promoter

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
2 Davis Drive
Research Triangle Park, NC, 27709
Phone: 9194910369